2021. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors.  Int J Radiat Oncol Biol Phys 111(1):272-283
,2021. Letter to the editor regarding the article "Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: Clinical implementation and initial experience" by Intven et al.  Radiother Oncol 158:244-245
,2021. Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio.  Breast Cancer 28(4):956-968
,2021. Pilot Study to Develop and Test Palliative Care Quality Indicators for Nursing Homes.  Int J Environ Res Public Health 18.
,2020. Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.  Int J Mol Sci 21.
,2020. Two-Level Factorial Pre-TomoBreast Pilot Study of Tomotherapy and Conventional Radiotherapy in Breast Cancer: Post Hoc Utility of a Mean Absolute Dose Deviation Penalty Score.  Technol Cancer Res Treat 19:1533033820947759
,2020. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.  J Immunol Res 2020:2192480
,2020. Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy.  Radiother Oncol 152:111-116
,2019. MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy.  Acta Oncol 58(2):232-236
,2019. Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?  Cancers (Basel) 11.
,2019. The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease.  Radiother Oncol 133:113-119
,2019. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems.  Cancer Lett 450:42-52
,2019. Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells.  Cancers (Basel) 11.
,2019. Healthcare utilization at the end of life in people dying from amyotrophic lateral sclerosis: A retrospective cohort study using linked administrative data.  J Neurol Sci 406:116444
,2018. Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend.  Front Immunol 9:2909
,2018. Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption.  Front Pharmacol 9:1073
,2018. Targeting antioxidant enzymes as a radiosensitizing strategy.  Cancer Lett 438:154-164
,2018. Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer.  Radiother Oncol 127(3):361-369
,2018. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI.  Acta Oncol 57(6):723-727
,2018. The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment.  Radiother Oncol 126(2):339-346
,2017. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.  Clin Pharmacokinet 56(8):953-961
,2017. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.  Oncotarget 8(22):35728-35742
,2017. Treating patients with Dynamic Wave Arc: First clinical experience.  Radiother Oncol 122(3):347-351
,2016. The cost of cancer care is not related to its outcomes.  Ecancermedicalscience 10:687
,2016. Corrigendum: Stromal contribution to the colorectal cancer transcriptome.  Nat Genet 48(10):1296
,2016. Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy: A 3-Year Follow-Up.  Int J Radiat Oncol Biol Phys 95(3):937-945
,2016. Motion management during SBRT for oligometastatic cancer: Results of a prospective phase II trial.  Radiother Oncol 119(3):519-24
,2016. Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc.  Radiat Oncol 11:63
,2016. Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy.  Oncotarget 7(27):42698-42715
,2016. Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion.  Radiother Oncol 119(2):291-9
,2016. Evaluation of a dedicated brain metastases treatment planning optimization for radiosurgery: a new treatment paradigm?  Radiat Oncol 11:13
,2016. Quality Assurance of a 50-kV Radiotherapy Unit Using EBT3 GafChromic Film: A Feasibility Study.  Technol Cancer Res Treat 15(1):163-70
,2016. Tangential IMRT versus TomoTherapy with and without breath-hold in left-sided whole breast irradiation.  Acta Oncol 55(2):240-3
,2015. Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer.  Oncotarget 6(14):12369-82
,2015. Advances in radiotherapy delivery for rectal cancer: a European perspective.  Expert Rev Gastroenterol Hepatol 9(4):393-7
,2015. Stromal contribution to the colorectal cancer transcriptome.  Nat Genet 47(4):312-9
,2015. A multi-centre analysis of treatment procedures and error components in dynamic tumour tracking radiotherapy.  Radiother Oncol 115(3):412-8
,2015. Geometric Verification of Dynamic Wave Arc Delivery With the Vero System Using Orthogonal X-ray Fluoroscopic Imaging.  Int J Radiat Oncol Biol Phys 92(4):754-61
,2015. A comparison of two clinical correlation models used for real-time tumor tracking of semi-periodic motion: A focus on geometrical accuracy in lung and liver cancer patients.  Radiother Oncol 115(3):419-24
,2015. Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy.  J Vis Exp.
,2015. Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system.  Radiother Oncol 117(3):487-90
,2014. Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer.  Radiother Oncol 111(1):106-9
,2014. Advances in radiotherapy and targeted therapies for rectal cancer.  World J Gastroenterol 20(1):1-5
,2014. Feasibility of using the Vero SBRT system for intracranial SRS.  J Appl Clin Med Phys 15(1):4437
,2014. Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery.  Radiat Oncol 9:36
,2014. Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome.  Radiother Oncol 110(1):155-9
,2014. Treating patients with real-time tumor tracking using the Vero gimbaled linac system: implementation and first review.  Radiother Oncol 112(3):343-51
,2014. Fiducial marker and marker-less soft-tissue detection using fast MV fluoroscopy on a new generation EPID: investigating the influence of pulsing artifacts and artifact suppression techniques.  Med Phys 41(10):101911
,2014. Impact of inadequate respiratory motion management in SBRT for oligometastatic colorectal cancer.  Radiother Oncol 113(2):235-9
,2014. Improving the intra-fraction update efficiency of a correlation model used for internal motion estimation during real-time tumor tracking for SBRT patients: fast update or no update?  Radiother Oncol 112(3):352-9
,2014. Analysis of the targeting uncertainty of a stereotactic frameless radiosurgery technique for arteriovenous malformation.  Radiother Oncol 113(3):371-3
,2014. Breast conserving treatment for breast cancer: dosimetric comparison of sequential versus simultaneous integrated photon boost.  Biomed Res Int 2014:827475
,2013. Initial assessment of tumor tracking with a gimbaled linac system in clinical circumstances: a patient simulation study.  Radiother Oncol 106(2):236-40
,2013. Hepatocytes determine the hypoxic microenvironment and radiosensitivity of colorectal cancer cells through production of nitric oxide that targets mitochondrial respiration.  Int J Radiat Oncol Biol Phys 85(3):820-7
,2013. Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas.  Radiother Oncol 106(2):192-7
,2013. Evaluation of the clinical usefulness for using verification images during frameless radiosurgery.  Radiother Oncol 108(1):114-7
,2013. A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.  Radiat Oncol 8:206
,2013. A complementary dual-modality verification for tumor tracking on a gimbaled linac system.  Radiother Oncol 109(3):469-74
,2013. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.  PLoS One 8(10):e76508
,2012. Clinical evaluation of a robotic 6-degree of freedom treatment couch for frameless radiosurgery.  Int J Radiat Oncol Biol Phys 83(1):467-74
,2012. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.  Int J Radiat Oncol Biol Phys 83(1):142-8
,2012. Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer.  Radiat Oncol 7:34
,2012. Computer-aided analysis of star shot films for high-accuracy radiation therapy treatment units.  Phys Med Biol 57(10):2997-3011
,2012. Scapula alata in early breast cancer patients enrolled in a randomized clinical trial of post-surgery short-course image-guided radiotherapy.  World J Surg Oncol 10:86
,2012. Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer.  Front Oncol 2:47
,2012. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.  Eur J Cancer 48(16):3045-51
,2012. Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.  Radiat Oncol 7:80
,2012. Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer.  Eur J Nucl Med Mol Imaging 39(10):1618-27
,2012. Parotid gland sparing with helical tomotherapy in head-and-neck cancer.  Int J Radiat Oncol Biol Phys 84(2):443-8
,2012. Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc.  Radiat Oncol 7:120
,2012. Early contralateral shoulder-arm morbidity in breast cancer patients enrolled in a randomized trial of post-surgery radiation therapy.  Breast Cancer (Auckl) 6:79-93
,2012. Small airways function in breast cancer patients before and after radiotherapy.  Breast Cancer Res Treat 135(3):857-65
,2012. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.  BMC Cancer 12:495
,2012. Setup accuracy of the Novalis ExacTrac 6DOF system for frameless radiosurgery.  Int J Radiat Oncol Biol Phys 82(5):1627-35
,2011. Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome.  Int J Radiat Oncol Biol Phys 80(5):1338-42
,2011. Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.  Int J Radiat Oncol Biol Phys 80(1):91-6
,2011. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.  Int J Radiat Oncol Biol Phys 81(4):e503-9
,2011. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial.  Int J Radiat Oncol Biol Phys 80(5):1343-9
,2011. Delivering affordable cancer care in high-income countries.  Lancet Oncol 12(10):933-80
,2011. Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system.  Radiother Oncol 98(3):365-72
,2010. Volumetric imaging by megavoltage computed tomography for assessment of internal organ motion during radiotherapy for cervical cancer.  Int J Radiat Oncol Biol Phys 77(5):1590-5
,2010. Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing.  Int J Radiat Oncol Biol Phys 76(5):1520-7
,2010. An in-house developed resettable MOSFET dosimeter for radiotherapy.  Phys Med Biol 55(4):N97-109
,2010. Toxicity and outcome results of a class solution with moderately hypofractionated radiotherapy in inoperable Stage III non-small cell lung cancer using helical tomotherapy.  Int J Radiat Oncol Biol Phys 77(5):1352-9
,2010. Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy.  Cancer 116(1):241-50
,2009. Volumetric response analysis during chemoradiation as predictive tool for optimizing treatment strategy in locally advanced unresectable NSCLC.  Radiother Oncol 91(3):438-42
,2009. Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowel.  Int J Radiat Oncol Biol Phys 74(5):1476-80
,2009. Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations.  Surg Neurol 72(4):423-8
,2008. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.  Bull Cancer 95(3):282-91
,2008. Phase II study of preoperative helical tomotherapy for rectal cancer.  Int J Radiat Oncol Biol Phys 70(3):728-34
,2008. A (short) history of image-guided radiotherapy.  Radiother Oncol 86(1):4-13
,2008. IFN-gamma+ CD8+ T lymphocytes: possible link between immune and radiation responses in tumor-relevant hypoxia.  Int J Radiat Oncol Biol Phys 71(3):647-51
,2008. Hypoxic tumor cell radiosensitization through nitric oxide.  Nitric Oxide 19(2):164-9
,2008. Assessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography.  Int J Radiat Oncol Biol Phys 71(3):934-9
,2008. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.  Anticancer Res 28(4C):2459-67
,2007. Innovations in image-guided radiotherapy.  Nat Rev Cancer 7(12):949-60
,2007. Prognostic value of histopathology and trends in cervical cancer: a SEER population study.  BMC Cancer 7:164
,2006. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.  Int J Radiat Oncol Biol Phys 66(5):1473-80
,2005. The role of chemotherapy in the treatment of low-grade glioma. A review of the literature.  Acta Neurol Belg 105(3):137-43
,2005. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.  Haematologica 90(6):810-7
,2004. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.  Int J Radiat Oncol Biol Phys 60(2):598-606
,2003. Metastases to the thyroid gland-a report of six cases.  Eur J Intern Med 14(6):377-379
,2003. Lipid a radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-kappaB signaling pathway.  Int J Radiat Oncol Biol Phys 57(3):779-86
,Publication list retrieved from NCBI using ImpactPubs
.